Cargando…
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
The Hippo pathway serves as a key barrier for oncogenic transformation. It acts by limiting the activity of the proto-oncogenes YAP and TAZ. Reduced Hippo signaling and elevated YAP/TAZ activities are frequently observed in various types of tumors. Emerging evidence suggests that the ubiquitin syste...
Autores principales: | Nguyen, Thanh Hung, Kugler, Jan-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923376/ https://www.ncbi.nlm.nih.gov/pubmed/29673168 http://dx.doi.org/10.3390/cancers10040121 |
Ejemplares similares
-
RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
por: Nguyen, Thanh Hung, et al.
Publicado: (2020) -
DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
USP21 regulates Hippo pathway activity by mediating MARK protein turnover
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
Regulation of the Hippo signaling pathway by ubiquitin modification
por: Kim, Youngeun, et al.
Publicado: (2018) -
Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
por: Watt, Kevin I., et al.
Publicado: (2017)